Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8B4T

Human cathepsin B in complex with the carbamate inhibitor 7

Summary for 8B4T
Entry DOI10.2210/pdb8b4t/pdb
DescriptorCathepsin B, (2S)-2-[[(2S)-2-[(4-chloranylphenoxy)carbonylamino]-3-cyclohexyl-propanoyl]amino]-3-phenyl-propanoic acid (3 entities in total)
Functional Keywordscathepsin b cysteine cathepsin inhibitor carbamate peptidomimetic cysteine proteinases, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight28429.12
Authors
Rubesova, P.,Guetschow, M.,Mares, M. (deposition date: 2022-09-21, release date: 2023-10-04, Last modification date: 2025-08-27)
Primary citationBreuer, C.,Kuppers, J.,Schulz-Fincke, A.C.,Heilos, A.,Lemke, C.,Spiwokova, P.,Schmitz, J.,Cremer, L.,Frigole-Vivas, M.,Lulsdorff, M.,Mertens, M.D.,Wichterle, F.,Apeltauer, M.,Horn, M.,Gilberg, E.,Furtmann, N.,Bajorath, J.,Bartz, U.,Engels, B.,Mares, M.,Gutschow, M.
Redirecting the Peptide Cleavage Causes Protease Inactivation.
Angew.Chem.Int.Ed.Engl., 64:e202506832-e202506832, 2025
Cited by
PubMed Abstract: Cysteine and serine proteases cleave peptides through covalent catalysis by generating a transient adduct with the N-terminal part of the substrate after releasing its C-terminal part. We demonstrate the unique redirection of this event leading to strong enzyme inactivation. For targeting human cathepsin B, a cysteine protease of significant therapeutic importance, we designed tailored peptidomimetics with a variety of dipeptide fragments directed toward the occluding loop and equipped with numerous N-terminal carbamate warheads. The carbamate deprotonation catalyzed by the active site thiolate initiates the redirected cleavage. The C-terminal part of the inhibitors remains covalently attached to the protease. Hydrolysis of such carbamoyl-enzyme complexes is catalytically unsupported rendering inhibition irreversible. This novel mechanism of action comprises a significant extension of the covalent drug space.
PubMed: 40394881
DOI: 10.1002/anie.202506832
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

240971

PDB entries from 2025-08-27

PDB statisticsPDBj update infoContact PDBjnumon